Blue Trust Inc. Cuts Position in United Therapeutics Co. (NASDAQ:UTHR)

Blue Trust Inc. lowered its holdings in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 18.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,149 shares of the biotechnology company’s stock after selling 256 shares during the quarter. Blue Trust Inc.’s […]